CHINA PH ARMACY Volume 33,Number 13,July 15,2022 Semimonthly Table of Contents Discussion on development difficulties and countermeasures of complex preparations in China
返回论文页
|更新时间:2022-11-09
|
CHINA PH ARMACY Volume 33,Number 13,July 15,2022 Semimonthly Table of Contents Discussion on development difficulties and countermeasures of complex preparations in China
China PharmacyVol. 33, Issue 13, (2022)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2022,
扫 描 看 全 文
SONG Bo, ZHENG Xiao, SHI Juan, et al. CHINA PH ARMACY Volume 33,Number 13,July 15,2022 Semimonthly Table of Contents Discussion on development difficulties and countermeasures of complex preparations in China. [J]. China Pharmacy 33(13).(2022)
DOI:
SONG Bo, ZHENG Xiao, SHI Juan, et al. CHINA PH ARMACY Volume 33,Number 13,July 15,2022 Semimonthly Table of Contents Discussion on development difficulties and countermeasures of complex preparations in China. [J]. China Pharmacy 33(13).(2022)DOI:
CHINA PH ARMACY Volume 33,Number 13,July 15,2022 Semimonthly Table of Contents Discussion on development difficulties and countermeasures of complex preparations in China
OBJECTIVE To discuss the difficulties in t he development of complex preparations and puts forward solutions ,in order to provide some reference for the development and preparation of complex preparations. METHODS Based on the development status of complex preparations ,the challenges faced by the development of complex preparations were analyzed ,and the countermeasures for the development of complex preparations were proposed. RESULTS & CONCLUSIONS The development of complex preparations required high quality of personnel ,and was limited by pharmaceutical excipients ,delivery devices and pharmaceutical equipment. The preparation process was complex ,there were many quality control parameters and patent barriers. Complex preparation development enterprises need to pay more attention to talents ,pharmaceutical excipients ,delivery devices and pharmaceutical equipment ,and clarify the impact of key technology on preparation production and quality characteristics ;in addition,they need to strengthen independent research and development ,crack the patent layout of original research enterprises and protect their own innovative achievements. Domestic complex preparation development enterprises can combine imitation and innovation to develop complex preparation products with independent brands to better meet the needs of patients.
Strategic exploration of the implementation of China’s drug patent linkage system corresponding to international rules
我国制药企业技术能力的提升——基于跨案例的研究
欧洲促进新抗菌药物研发的措施及经验
中药仿制一致性评价的思考
原研与国产仿制抗菌药物药品说明书的对比分析
Related Author
WANG Yuan
SHAO Rong
YAN Jianzhou
陈乃用 张化尧
冯晶晶 王小万 崔月颖
王茹茹 何祖新
龚海虹 林志强
吕亚军?蚩晓娜?谷志勇
Related Institution
Scientific Research Institute of Drug Administration, China Pharmaceutical University/Key Laboratory for Drug Regulatory Innovation and Evaluation, National Medical Products Administration